Table 5.
The effect of vitamin D treatment on ambulation and lower extremity motor function in patients with stroke in the first 3 months after stroke.
| Vitamin D | |||
|---|---|---|---|
| Control (n = 22) | Vitamin D (n = 16) | p-value | |
| FAC | |||
| Prerehab | 1.5 (0–5) | 1 (0–4) | 0.795 |
| Postrehab | 2.5 (0–5) | 4 (1–5) | 0.251 |
| Change | 0 (0–3) | 2 (0–5) | 0.005 |
| BRS | |||
| Prerehab | 3.5 (1–6) | 3,5 (1–6) | 0.978 |
| Postrehab | 4.5 (1–6) | 5 (2–6) | 0.171 |
| Change | 0 (0–2) | 1 (0–5) | 0.047 |
| Vitamin D* levels (ng/mL) | 17.5 (8–26) | 13 (8–36) | 0.200 |
Values are presented as median (min–max). FAC: functional ambulation classification, BRS: